Law360, New York (March 11, 2013, 1:59 PM EDT) -- A Massachusetts federal judge on Friday upheld a jury's verdict that found two antibody patents held by Abbott GmbH & Co. KG were invalid, finalizing a courtroom win for Johnson & Johnson subsidiary Janssen Biotech Inc.
U.S. District Judge F. Dennis Saylor rejected various post-trial motions filed by Abbott, which had accused Janssen of infringing the two patents by selling the psoriasis treatment Stelara. The decision means the jury's September verdict that both patents were invalid will be entered as final judgment.
Abbott had asked for...
J&J's Win Upheld In Antibody Patent Fight Against Abbott
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
